Modular Medical (Nasdaq:MODD) announced today that it validated its insulin pump cartridge line for human-use production in the U.S.
TWINSBURG, Ohio, July 15, 2025 /PRNewswire/ — Edgepark has recently expanded its portfolio to include the latest innovations from diabetes manufacturers, including the first-ever FDA-cleared yearlong continuous glucose monitor (CGM) system, and a glucose biosensor that can be purchased without a prescription.
New imaging innovation enhances wound assessment by combining fluorescence and thermal data for improved diagnostic precision and patient care
Sequel Med Tech announced at the American Diabetes Association’s 85th Scientific Sessions in Chicago that it plans to launch its twiist system in July.
Next-gen portable ultrasound system combines speed, image clarity, and AI-powered tools to elevate diagnostic confidence at the bedside.
New leadership and AI-driven technology aim to revolutionize assessment and care for brain-related conditions
SUNNYVALE, Calif., June 10, 2025 /PRNewswire/ — In a major milestone for heart failure treatment, the first commercial patients in the U.S. have been successfully implanted with the FDA-approved WiSE® System—marking the beginning of a new chapter in leadless left ventricular endocardial pacing (LVEP) for the treatment of heart failure.
Breakthrough Non-Invasive Therapy Installed with Support from Li Ka Shing Foundation to Advance Research and Patient Care
EnVVeno Medical (Nasdaq:NVNO) announced three-year outcomes for its heart valve that it aims to submit to the FDA this year.
Revolutionary system combines ultrasonics and ultraviolet energy to destroy airborne pathogens and pollutants beyond traditional purification limits.